VOLITIONRX LTD - VNRX

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$4.899M
QoQ value delta ($000)
+$782K (+18.99%)
Implied price effect (QoQ)
-19.65%
Shares
Total shares
23,905,328
QoQ shares delta
+7,762,450 (+48.09%)
Total shares held by funds (by quarter)

Market chart (VNRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 31 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Lagoda Investment Management, L.P. 3,262 16,149,000 2.01%
VANGUARD GROUP INC 391 1,530,048 0.0%
GEODE CAPITAL MANAGEMENT, LLC 248 1,230,083 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 204 1,013,673 0.0%
LUMINUS MANAGEMENT LLC 200 995,000 0.12%
STATE STREET CORP 137 679,938 0.0%
VANGUARD FIDUCIARY TRUST CO 101 502,657 0.0%
BlackRock, Inc. 90 446,187 0.0%
NORTHERN TRUST CORP 52 259,593 0.0%
Silverberg Bernstein Capital Management LLC 50 251,215 0.03%
Wealthspire Advisors, LLC 44 220,000 0.0%
UBS Group AG 41 207,430 0.0%
Bank of New York Mellon Corp 11 55,596 0.0%
GROUP ONE TRADING LLC 10 50,000 0.0%
XTX Topco Ltd 9 46,060 0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 8 39,999 0.0%
Cetera Investment Advisers 8 40,550 0.0%
Tower Research Capital LLC (TRC) 7 36,328 0.0%
Miller Financial Services LLC 6 31,000 0.01%
PFG Investments, LLC 5 25,000 0.0%
TWO SIGMA SECURITIES, LLC 3 15,785 0.0%
SANDERS MORRIS HARRIS LLC 3 15,000 0.0%
Creative Planning 2 12,834 0.0%
Integrated Wealth Concepts LLC 2 10,000 0.0%
Vanguard Global Advisers, LLC 2 13,718 0.0%